For the quarter ending 2025-09-30.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
| Revenue | - | 0 | - | 2 |
| Research and development | 4,741 | 4,758 | 4,698 | 5,265 |
| General and administrative | 3,453 | 3,034 | 3,118 | 3,671 |
| Total operating expenses | 8,194 | 7,792 | 7,816 | 8,936 |
| Loss from operations | -8,194 | -7,792 | -7,816 | -8,931 |
| Interest income | 175 | 224 | 184 | -45 |
| Gain on extinguishment of accounts payable | - | - | - | 93 |
| Bond accretion income | 69 | 112 | 140 | 472 |
| Total other income, net | 244 | 336 | 324 | 519 |
| Net loss | -7,950 | -7,456 | -7,492 | -8,413 |
| Net unrealized gain (loss) on investments | 5 | -26 | - | - |
| Comprehensive loss | -7,945 | -7,482 | - | - |
| Loss per share - basic | -0.21 | -0.2 | -0.21 | -0.27 |
| Loss per share - diluted | -0.21 | -0.2 | -0.21 | -0.27 |
| Weighted-average shares outstanding - basic | 37,893,314 | 37,946,330 | 34,926,075 | -16,385,486 |
| Weighted-average shares outstanding - diluted | 37,893,314 | 37,946,330 | 34,926,075 | -16,385,486 |
GENELUX Corp (GNLX)
GENELUX Corp (GNLX)